Abstract:Background: Helicobacter pylori (H. pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer. Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases, including stomach-associated diseases. This study is aimed at evaluating the antimicrobial activity of TASA on H. pylori-infected BALB/c mice mouse gastritis. Methods: Totally 120 BALB/c mice were orally inoculated with H. pylori Bacterial liquid to construct BALB/c mice H. pylori infection gastritis animal model, after the model was successfully created. We randomly assigned 100 infected mice into 10 treatment groups, the first group (normal saline); the second group (bismuth pectin); the third group (omeprazole); the fourth group (TASA 2 mg/d); the fifth group (TASA 4 mg/d); the sixth group (TASA 5 mg/d); the seventh group (TASA + bismuth pectin); the eighth group (TASA + omeprazole); the ninth group (bismuth pectin + clarithromycin + metronidazole); the tenth group (omeprazole + clarithromycin + metronidazole), 5 other non-infected mice as negative control. Mice were orally inoculated twice a day and 7 days continuously. Then the mice were killed 4 weeks after treatment, we used realtime PCR to detect 16sDNA of H. pylori to test both the colonization and the clearance mice of bacteria of each treatment. We applied hematoxylin and eosin (HE) staining and immunostaining of mice gastric mucosa to observe the general inflammation and related factors interleukin 8 (IL-8), cyclooxygenase 2 (COX-2), and nuclear factor-kappa B (NF-κB) expression change after treatments. Results: Firstly, we ensured that after 6-week intragastric administration, the bacteria colonization reached an exceed peak which is far higher than positive threshold (P < 0.001); secondly, after treatments, it is revealed that TASA combined with omeprazole or bismuth pectin showed promising antimicrobial activity against H. pylori as well as conventional triple therapy (P < 0.001); thirdly, HE staining showed that the inflammation on mice gastric mucosal membrane were also relieved obviously in TASA combined treatments and conventional triple therapy compared with normal saline treated mice, moreover, from immunohistochemistry results, H. pylori-induced IL-8, COX-2, and NF-κB were consistently suppressed in seventh, eighth, ninth, and tenth group to a certain extent. Conclusion: These results open the possibility of taking TASA as an anti-inflammatory agent for H. pylori gastritis.

[Preventive Effects of Teprenone on Gastric Mucosal Lesions Induced by Helicobacter Pylori in Mice].

Effect of teprenone on gastric mucosal injury induced by Helicobacter pylori in rats

Clinical efficacy of teprenone on 92 patients with ethanol-induced chronic gastritis

Effect of Protective Agent of Gastric Mucosa on Expression of Heat Shock Protein 70 in Rats with Chronic Atrophic Gastritis

[Effect of Mucosal Protective on the Quality of Gastric Ulcer Healing].

Preventive effects of gastric mucosal protective on H pylori CCS-induced gastric mucosal lesion in rats

[Side effects of non-steroidal anti-inflammatory drugs on gastric mucosa and preventive effects of teprenone].

Effect of Hydrotalcite on Indometacin-Induced Gastric Injury in Rats

The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries

Protective Effects of Extracts from Polygonum Hydropiper L on Ethanol-Induced Acute Gastric Mucosal Lesions

Teprenone improves gastric mucosal injury and dyspeptic symptoms in long term nonsteroidal anti-inflammatory drug users.

[Protective Effects of Sucralfate on Gastric Mucosal Injury Induced by Helicobacter Pylori and Its Effects on Gastrointestinal Flora in Mice].

[Non-Steroidal Anti-Inflammatory Drug Induced Gastropathy and Preventive Effects of Teprenone on the Gastropathy in Rats].

Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter Pylori and Its Effect on Gastrointestinal Flora.

The effects of teprenone on the ulcer healing rate and the quality of healing in the treatment of patients with active gastric ulcer

Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo

The protective effect of teprenone in TNBS-induced ulcerative colitis rats by modulating the gut microbiota and reducing inflammatory response

Effects of mucosal protective agents against experimental gastric mucosal lesions and ultra-structure changes in gastric mucosal in rats

Effect of teprenone combined with esomeprazole on prevention ofgastriculcer after gastric ESD evaluated with endoscope assistant softwares

Therapeutic Effect of Water Extract from Xiao-Jian-Zhong-Tang on Injury of Gastric Mucosa Caused by Helicobacter pylori Infection in Mice

Preventive and Therapeutic Effects of Rana Chensinensis Skin Extracts on Experimental Gastric Ulcers